Oxford Biomedical Technologies is the true leader in the field of food sensitivity testing. Oxford offers the patented Mediator Release blood test (MRT), the most innovative and clinically useful test for hidden inflammatory responses to foods and food-chemicals.
MRT, when combined with a highly effective LEAP anti-inflammatory eating plan, provides quick and lasting relief for irritable bowel syndrome, migraine, fibromyalgia, and a wide range of other food sensitivity related health problems. Both MRT and LEAP are foundational components of optimal health and wellness.
Measures the function of 35 nutritional components including vitamins, antioxidants, minerals and amino acids within our white blood cells. Scientific evidence shows us that analyzing the white blood cells gives us the most accurate analysis of a body’s deficiencies.
Cardiovascular disease is the leading cause of death. Standard cholesterol tests can miss that YOU are at risk. SpectraCells CardioMetabolic test offers a clinically relevant evaluation to help define risk for atherosclerotic cardiovascular disease (ASCVD), progression toward Type 2 Diabetes, and inflammation. It includes SpectraCells Advanced Lipoprotein Particle Profile Plus (LPPTM Plus), which measures lipoprotein size and density; cardiovascular risk stratification; and also includes triglycerides and traditional cholesterol screening. Each patient is assigned a CardioMetabolic Risk Assessment, which is an indication of your risk (Low, Moderate or High) for developing cardiovascular disease, including stroke and diabetes. In addition, the Type 2 Diabetes Risk Assessment is an estimate of your risk of developing Type 2 Diabetes. These check points help patients understand that not just one factor, but rather a constellation of risk factors, contribute to the genesis and progression toward poor blood sugar control and/or ASCVD.
The methylenetetrahydrofolate reductase (MTHFR) mutation test is used to detect two relatively common mutations in the MTHFR gene that are associated with elevated levels of homocysteine in the blood.
Genova Comprehensive Stool
The Comprehensive Digestive Stool Analysis (CDSA) offers a comprehensive look at the overall health of the gastrointestinal (GI) tract. The CDSA is Genova’s historic evaluation of gastrointestinal function assessing a select set of stool biomarkers.
Evidence suggests that both local and systemic health issues may begin as imbalances in gastrointestinal function. Some of the consequences of imbalanced gastrointestinal health are:
Irritable Bowel Syndrome (IBS)
Altered GI immune function
The Metabolic Analysis Profile is a nutritional test that assesses urine metabolites in order to evaluate four critical areas of metabolism: gastrointestinal function, cellular and mitochondrial energy production, neurotransmitter processing, and amino acid/organic acid balance as influenced by vitamin/mineral cofactors. Results can be used to address chronic systemic complaints ranging from chronic fatigue and mood disorders to headache, muscular/joint pain, and digestive problems.
The Metabolic Analysis Profile is a nutritional test using an urinary assessment of 46 key organic acids grouped according to their primary roles in the following four central areas of metabolism.
Gastrointestinal Function This profile measures eight markers that can reveal malabsorption and dysbiosis. These imbalances can be addressed to improve gut health and to help prevent or alleviate: chronic digestive problems, common causes of nutritional deficiency, yeast overgrowth, cognitive impairment, gastrointestinal distress, and degenerative conditions.
Precision Analytics Hormone
The most comprehensive analysis of sex and adrenal hormones, this profile includes the DUTCH Adrenal and Sex Hormone Metabolite as well as an overnight melatonin measurement. This test includes 4 easy-to-collect dried urine samples collected on filter paper devices.